Skip to content

CARDIFF ONCOLOGY, INC.: 10-Q filed 2020-08-11

What CARDIFF ONCOLOGY, INC. reported in its quarterly report filed 2020-08-11 (fiscal Q2 2020): 37 published measures, 100 facts as tagged in accession 0001628280-20-012428.

This filing

Form
10-Q (quarterly report)
Filed
2020-08-11
Fiscal period
fiscal Q2 2020
Accession
0001628280-20-012428 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CARDIFF ONCOLOGY, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2020-06-3030,128,979USD
At 2019-12-3113,086,546USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2020-06-305,744,940USD
At 2019-12-315,775,202USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2020-06-3024,384,039USD
At 2020-03-316,143,418USD
At 2019-12-317,311,344USD
At 2019-06-308,848,235USD
At 2019-03-319,686,181USD
At 2018-12-3110,084,192USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2020-06-3027,754,813USD
At 2019-12-3110,195,292USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-4,124,532USD91
2020-01-01 to 2020-06-30-8,213,094USD182
2020-01-01 to 2020-03-31-4,088,562USD91
2019-04-01 to 2019-06-30-4,125,303USD91
2019-01-01 to 2019-06-30-8,030,074USD181
2019-01-01 to 2019-03-31-3,904,771USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2020-01-01 to 2020-06-30-7,665,787USD182
2019-01-01 to 2019-06-30-6,803,159USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2020-01-01 to 2020-06-300USD182
2019-01-01 to 2019-06-305,274USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2020-04-01 to 2020-06-3042,633USD91
2020-01-01 to 2020-06-30110,337USD182
2019-04-01 to 2019-06-3038,348USD91
2019-01-01 to 2019-06-30100,369USD181

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2020-04-01 to 2020-06-3042,633USD91
2020-01-01 to 2020-06-30110,337USD182
2019-04-01 to 2019-06-3036,852USD91
2019-01-01 to 2019-06-3098,873USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2020-01-01 to 2020-06-3025,225,308USD182
2019-01-01 to 2019-06-306,146,570USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2020-01-01 to 2020-06-300USD182
2019-01-01 to 2019-06-30-5,274USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2020-06-30-220,389,581USD
At 2019-12-31-208,897,883USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2020-06-30655,367USD
At 2019-12-31877,823USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2020-01-01 to 2020-06-30459,085USD182
2019-01-01 to 2019-06-30348,901USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-4,102,316USD91
2020-01-01 to 2020-06-30-8,226,322USD182
2019-04-01 to 2019-06-30-4,219,959USD91
2019-01-01 to 2019-06-30-8,181,722USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2020-06-3028,819,133USD
At 2019-12-3111,353,729USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2020-06-304,962,029USD
At 2019-12-314,781,744USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2020-06-301,155,531USD
At 2019-12-31656,304USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2020-06-30109,334USD
At 2019-12-31203,480USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2020-04-01 to 2020-06-304,144,949USD91
2020-01-01 to 2020-06-308,336,659USD182
2019-04-01 to 2019-06-304,258,307USD91
2019-01-01 to 2019-06-308,282,091USD181

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2020-04-01 to 2020-06-301,669,227USD91
2020-01-01 to 2020-06-303,155,246USD182
2019-04-01 to 2019-06-301,427,967USD91
2019-01-01 to 2019-06-302,803,152USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2020-06-3021,325,076shares
At 2019-12-318,593,633shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2020-06-3027,754,813USD
At 2019-12-3110,195,292USD
At 2019-06-3010,791,270USD
At 2018-12-3111,453,133USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2020-06-30247,528,273USD
At 2019-12-31217,172,528USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2020-06-30501,894USD
At 2019-12-31697,418USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2020-06-301,307,383USD
At 2019-12-311,726,342USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2020-06-303,493,570USD
At 2019-12-313,482,116USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2020-06-302,838,203USD
At 2019-12-312,604,293USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2020-06-30152,585USD
At 2019-12-31157,576USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2020-06-3072,701USD
At 2019-12-31128,368USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2020-06-302,858,161USD
At 2019-12-313,260,061USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-7,397,076USD91
2020-01-01 to 2020-06-30-11,491,698USD182
2019-04-01 to 2019-06-30-4,131,363USD91
2019-01-01 to 2019-06-30-8,310,463USD181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2020-01-01 to 2020-06-30233,909USD182
2019-01-01 to 2019-06-30248,958USD181

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2020-04-01 to 2020-06-306,257USD91
2020-01-01 to 2020-06-303,771USD182
2019-04-01 to 2019-06-301,106USD91
2019-01-01 to 2019-06-303,116USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2020-01-01 to 2020-06-3018,801,924USD182
2019-01-01 to 2019-06-302,902,740USD181

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2020-04-01 to 2020-06-30236,385USD91
2020-01-01 to 2020-06-30469,463USD182
2019-04-01 to 2019-06-30229,574USD91
2019-01-01 to 2019-06-30455,938USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-06-30-94,146USD182
2019-01-01 to 2019-06-30-45,474USD181

Inspect the source

Entity
CARDIFF ONCOLOGY, INC. / CIK 0001213037
Captured
2026-09-20T07:45:48.177Z
SEC response SHA-256
5fefa7380123168da913afadb8db67f9296559e6467fa58ab3879c6c623fb326

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001213037.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))